
Countable Labs is transforming how biology is measured- bringing single-molecule precision to cell and gene therapy, oncology, molecular diagnostics, and other applications that demand the highest analytical performance. Countable PCR delivers at least 10 times the sensitivity of conventional PCR, with dynamic range and quantitative accuracy that existing digital PCR and next-generation sequencing approaches have not achieved - enabling detection and quantification of rare targets with a level of confidence that fundamentally changes what's measurable.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 06/01/26 | $26,000,000 | Venture |
ARCH Venture Partners![]() F-Prime Capital Partners Primer Ventures | undisclosed |